ScholarGate
Asistent

Porovnať metódy

Prezrite si vybrané metódy vedľa seba; riadky, ktoré sa líšia, sú zvýraznené.

Meta-analytická analýza konkurenčných rizík×Metaanalytická analýza prežitia – Združovanie dôkazov o čase do udalosti×
OdborEpidemiológiaEpidemiológia
RodinaProcess / pipelineProcess / pipeline
Rok vzniku2000s–2010s (formalized as a pooled approach)1990s–2000s (formalized ~1998)
TvorcaBased on Fine & Gray (1999) competing risks framework; meta-analytic synthesis methods established through methodological literature (mid-2000s onward)Parmar, Torri & Stewart (statistical framework); broader IPD tradition developed by the Early Breast Cancer Trialists' Collaborative Group
TypSystematic review / meta-analysisQuantitative synthesis / meta-analytic method
Pôvodný zdrojRiley, R. D., Hayden, J. A., Steyerberg, E. W., et al. (2013). Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research. PLOS Medicine, 10(2), e1001380. DOI ↗Parmar, M. K. B., Torri, V., & Stewart, L. (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine, 17(24), 2815–2834. DOI ↗
Ďalšie názvymeta-analysis of competing risks, pooled competing risks analysis, systematic review competing risksmeta-analysis of time-to-event data, pooled survival analysis, IPD survival meta-analysis, aggregate survival meta-analysis
Príbuzné54
ZhrnutieMeta-analytic competing risks analysis pools results from multiple primary studies that each used a competing risks framework, allowing summary estimates of cause-specific or subdistribution hazard ratios and cumulative incidence functions. Because standard meta-analytic methods may misrepresent competing events, specialized pooling strategies are required that respect the subdistribution hazard structure introduced by Fine and Gray and the distinction between cause-specific and all-cause hazard models.Meta-analytic survival analysis is a quantitative synthesis method that pools hazard ratios and related time-to-event statistics from multiple independent studies to produce a single, more precise estimate of a treatment or exposure effect on survival outcomes such as overall survival, disease-free survival, or time to relapse. It can operate on aggregate published data or on individual patient data (IPD) contributed directly by study investigators.
ScholarGateDátová sada
  1. v1
  2. 2 Zdroje
  3. PUBLISHED
  1. v1
  2. 2 Zdroje
  3. PUBLISHED

Prejsť na hľadanie Stiahnuť snímky

ScholarGatePorovnať metódy: Meta-analytic competing risks analysis · Meta-analytic survival analysis. Získané 2026-06-18 z https://scholargate.app/sk/compare